Product
Concomitant treatment
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2021-09-01